<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03233100</url>
  </required_header>
  <id_info>
    <org_study_id>STC-D-A-2017-FMT</org_study_id>
    <nct_id>NCT03233100</nct_id>
  </id_info>
  <brief_title>FMT Treating Constipation Patients With Depression and/or Anxiety Symptoms - Clinical Efficacy and Potential Mechanisms</brief_title>
  <official_title>FMT Treating Constipation Patients With Depression and/or Anxiety Symptoms - Clinical Efficacy and Potential Mechanisms</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jianfeng Gong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Jinling Hospital, China</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Constipated patients often have mental problems such as depression and anxiety due to
      difficult defecation. Our previous studies have proved the efficacy of FMT treating
      constipation. Meanwhile it is believed that mental diseases are correlated to gut microbiota.
      This trial is based on the theory of the gut-brain-microbiota axis. Patients with
      constipation, depression and/or anxiety are performed FMT, laboratory, imaging and microbiota
      examinations, and clinical follow-up, to observe the clinical efficiency of FMT and the
      potential role of gut microbiome in these gut-brain disorders.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">July 30, 2017</start_date>
  <completion_date type="Anticipated">December 31, 2018</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>CSBMs per week</measure>
    <time_frame>12 weeks after treatment</time_frame>
    <description>complete spontaneous bowl movements per week</description>
  </primary_outcome>
  <primary_outcome>
    <measure>HAMA</measure>
    <time_frame>12 weeks after treatment</time_frame>
    <description>score of Hamilton Anxiety Rating Scale</description>
  </primary_outcome>
  <primary_outcome>
    <measure>HAMD</measure>
    <time_frame>12 weeks after treatment</time_frame>
    <description>score of Hamilton Depression Rating Scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Wexner</measure>
    <time_frame>pre, 2 weeks, 4 weeks, 8 weeks, 12weeks</time_frame>
    <description>score of Wexner</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PAC-SYM</measure>
    <time_frame>pre, 2 weeks, 4 weeks, 8 weeks, 12weeks</time_frame>
    <description>score of PAC-SYM</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bristol Bristol PAC-SYM</measure>
    <time_frame>pre, 2 weeks, 4 weeks, 8 weeks, 12weeks</time_frame>
    <description>score of Bristol score of Bristol</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PAC-QOL</measure>
    <time_frame>pre, 2 weeks, 4 weeks, 8 weeks, 12weeks</time_frame>
    <description>score of PAC-QOL</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Gut microbiota analysis</measure>
    <time_frame>pre, 4 weeks, 12 weeks</time_frame>
    <description>Gut microbiota analysis</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Constipation - Functional</condition>
  <condition>Depressive Symptoms</condition>
  <condition>Anxiety Symptoms</condition>
  <condition>Gut-Brain Disorders</condition>
  <arm_group>
    <arm_group_label>FMT group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>FMT</intervention_name>
    <description>fecal microbiota transplantation</description>
    <arm_group_label>FMT group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who were diagnosed as functional constipation (FC) according to Rome Ⅳ
             criteria were enrolled.

          -  Age ≥ 18 years

          -  Body mass index of 18-25 kg/m2.

          -  HAMA ≥ 14 and/or HAMD (17 items) ≥ 17

        Exclusion Criteria:

          -  History of sever mental disorders such as schizophrenia and bipolar disorder

          -  History of organic intestinal disorders

          -  History of gastrointestinal surgery

          -  Pregnant or breast-feeding women

          -  Infection with enteric pathogen

          -  Usage of probiotics, prebiotics, antibiotics within the last month

          -  Uncontrolled hepatic, renal, cardiovascular, and respiratory, or any diseases that in
             the opinion of the investigator, could affect intestinal transit and the intestinal
             microbiota.

          -  Patients who could not complete the follow-up
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jianfeng Gong, MD</last_name>
    <phone>+86-25-80860036</phone>
    <email>gongjianfeng@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Generay Surgery, Jinling hosptal, Medical School of Nanjing University</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jianfeng Gong, MD</last_name>
      <phone>+86-25-80860036</phone>
      <email>gongjianfeng@aliyun.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 22, 2017</study_first_submitted>
  <study_first_submitted_qc>July 25, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 28, 2017</study_first_posted>
  <last_update_submitted>July 25, 2017</last_update_submitted>
  <last_update_submitted_qc>July 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 28, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Jinling Hospital, China</investigator_affiliation>
    <investigator_full_name>Jianfeng Gong</investigator_full_name>
    <investigator_title>Professor, Associate senior doctor</investigator_title>
  </responsible_party>
  <keyword>FMT</keyword>
  <keyword>gut microbiota</keyword>
  <keyword>gut-brain disorder</keyword>
  <keyword>constipation</keyword>
  <keyword>depression</keyword>
  <keyword>anxiety</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Anxiety Disorders</mesh_term>
    <mesh_term>Constipation</mesh_term>
    <mesh_term>Brain Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

